About Index Trending news
Analyze
Pricing
Exosome Diagnostics

Exosome Diagnostics

Exosome Diagnostics

Developing and commercializing personalized biofluid-based diagnostic tests for use in companion diagnostic applications and real-time disease monitoring.
I work here Suggest edits
More info

Elsewhere

Contributors to this profile

Also headquartered in Cambridge

MIT MIT Raspberry Pi Raspberry Pi ARM ARM Xconomy Xconomy HubSpot HubSpot Mobile.co Mobile.co nuTonomy nuTonomy Biogen Biogen Hopper Hopper General Catalyst General Catalyst

Companies in the same industry

CVRx CVRx NanoCellect Biomedical, Inc. NanoCellect Biomedical, Inc. GeneCast Biotechnology GeneCast Biotechnology Oxford Nanopore Oxford Nanopore Daktari Diagnostics Daktari Diagnostics PathGroup PathGroup Inbiomotion Inbiomotion Sequenom Sequenom Advanced Cell Dx Advanced Cell Dx Solulink Solulink

Alexa global traffic share

Twitter followers

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 6
Add info
Add round
24 Jul 2017
$30,000,000
Venture capital (Series C)
CD-Venture, Arcus Ventures, NGN Capital, +4

citybizlist : Exosome Diagnostics Raises $30M Series C

citybizlist
07 Jan 2016
$60,000,000
Venture capital (Series B)
Tiger Management, Qiagen, Arcus Ventures, +4

Exosome Diagnostics Completes $60 Million Series B Financing

businesswire
+2
02 Sep 2015
$17,600,000
Venture capital (Series B)
Tiger Management, CD-Venture, Arcus Ventures, +2

Exosome Diagnostics Raises $17.6 Million in Second Round Series B Financing

BioPortfolio
06 Jul 2015
$1,500,000
Venture capital
11 Mar 2014
$27,000,000
Venture capital (Series B)
b-to-v Partners AG, Qiagen, Arcus Ventures, +2

Exosome Diagnostics raises USD 27m in Series B Financing Partners AG

b-to-v
+1
11 May 2010
$20,000,000
Venture capital (Series A)
NGN Capital, Forbion Capital Partners